Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis.

Prevymis (letermovir) - Merck (MSD)

Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis. (PubMed, Bone Marrow Transplant) - Aug 6, 2026 - No abstract available
Journal • Real-world evidence • Bone Marrow Transplantation • Transplantation

http://www.ncbi.nlm.nih.gov/pubmed/42552371

Aiming Pang; Donglin Yang; Erlie Jiang; Jialin Wei; Jieya Luo; Mingzhe Han; Rongli Zhang; Ruixin Li; Sizhou Feng; Weihua Zhai; Wenhao Wang; Xin Chen; Xueyao Li; Yi He; Yigeng Cao

Aug 6, 2026